|
1
|
Metzger BE, Buchanan TA, Coustan DR, et
al: Summary and recommendations of the Fifth International
Workshop-Conference on Gestational Diabetes Mellitus. Diabetes
Care. 30:S251–S260. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xiong X, Saunders L, Wang F and Demianczuk
N: Gestational diabetes mellitus: prevalence, risk factors,
maternal and infant outcomes. Int J Gynaecol Obstet. 75:221–228.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Landon MB, Spong CY, Thom E, et al; Eunice
Kennedy Shriver National Institute of Child Health and Human
Development Maternal-Fetal Medicine Units Network. A multicenter,
randomized trial of treatment for mild gestational diabetes. N Engl
J Med. 361:1339–1348. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fernández-Real JM and Pickup JC: Innate
immunity, insulin resistance and type 2 diabetes. Trends Endocrinol
Metab. 19:10–16. 2008.PubMed/NCBI
|
|
5
|
Greenberg A and McDaniel M: Identifying
the links between obesity, insulin resistance and β-cell function:
potential role of adipocyte-derived cytokines in the pathogenesis
of type 2 diabetes. Eur J Clin Invest. 32(Suppl 3): 24–34.
2002.
|
|
6
|
Medzhitov R: Toll-like receptors and
innate immunity. Nat Rev Immunol. 1:135–145. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hill HR, Hogan NA, Rallison ML, et al:
Functional and metabolic abnormalities of diabetic monocytes. Adv
Exp Med Biol. 141:621–628. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kolek MJ, Carlquist JF, Muhlestein JB, et
al: Toll-like receptor 4 gene Asp299Gly polymorphism is associated
with reductions in vascular inflammation, angiographic coronary
artery disease, and clinical diabetes. Am Heart J. 148:1034–1040.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nitsche JF, Jiang SW and Brost BC:
Toll-like receptor-2 and toll-like receptor-4 expression on
maternal neutrophils during pregnancy. Am J Reprod Immunol.
64:427–434. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kajikawa O, Frevert CW, Lin SM, et al:
Gene expression of Toll-like receptor-2, Toll-like receptor-4, and
MD2 is differentially regulated in rabbits with Escherichia
coli pneumonia. Gene. 344:193–202. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shi H, Kokoeva MV, Inouye K, Tzameli I,
Yin H and Flier JS: TLR4 links innate immunity and fatty
acid-induced insulin resistance. J Clin Invest. 116:3015–3025.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nguyen MA, Favelyukis S, Nguyen AK, et al:
A subpopulation of macrophages infiltrates hypertrophic adipose
tissue and is activated by free fatty acids via Toll-like receptors
2 and 4 and JNK-dependent pathways. J Biol Chem. 282:35279–35292.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
American Diabetes Association. Diagnosis
and classification of diabetes mellitus. Diabetes Care. 29(Suppl
1): S43–S48. 2006.
|
|
14
|
Akira S, Takeda K and Kaisho T: Toll-like
receptors: critical proteins linking innate and acquired immunity.
Nat Immunol. 2:675–680. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dasu MR, Devaraj S, Zhao L, Hwang DH and
Jialal I: High glucose induces toll-like receptor expression in
human monocytes: mechanism of activation. Diabetes. 57:3090–3098.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhande R, Dauphinee SM, Thomas JA,
Yamamoto M, Akira S and Karsan A: FADD negatively regulates
lipopolysaccharide signaling by impairing interleukin-1
receptor-associated kinase 1-MyD88 interaction. Mol Cell Biol.
27:7394–7404. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Di Benedetto A, Russo G, Corrado F, et al:
Inflammatory markers in women with a recent history of gestational
diabetes mellitus. J Endocrinol Invest. 28:34–38. 2005.PubMed/NCBI
|
|
18
|
Devaraj S, Dasu MR, Rockwood J, Winter W,
Griffen SC and Jialal I: Increased toll-like receptor (TLR) 2 and
TLR4 expression in monocytes from patients with type 1 diabetes:
further evidence of a proinflammatory state. J Clin Endocrinol
Metab. 93:578–583. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mohammad MK, Morran M, Slotterbeck B, et
al: Dysregulated Toll-like receptor expression and signaling in
bone marrow-derived macrophages at the onset of diabetes in the
non-obese diabetic mouse. Int Immunol. 18:1101–1113. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu YC, Yeh WC and Ohashi PS: LPS/TLR4
signal transduction pathway. Cytokine. 42:145–151. 2008. View Article : Google Scholar
|
|
21
|
Mullick AE, Tobias PS and Curtiss LK:
Toll-like receptors and atherosclerosis: key contributors in
disease and health? Immunol Res. 34:193–209. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schulthess FT, Paroni F, Sauter NS, et al:
CXCL10 impairs β cell function and viability in diabetes through
TLR4 signaling. Cell Metab. 9:125–139. 2009.
|
|
23
|
Buchanan TA and Xiang AH: Gestational
diabetes mellitus. J Clin Invest. 115:485–491. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dandona P, Aljada A and Bandyopadhyay A:
Inflammation: the link between insulin resistance, obesity and
diabetes. Trends Immunol. 25:4–7. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hussey SE, Liang H, Costford SR, et al:
TAK-242, a small-molecule inhibitor of Toll-like receptor 4
signalling, unveils similarities and differences in
lipopolysaccharide- and lipid-induced inflammation and insulin
resistance in muscle cells. Biosci Rep. 33:37–47. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Reyna SM, Ghosh S, Tantiwong P, et al:
Elevated toll-like receptor 4 expression and signaling in muscle
from insulin-resistant subjects. Diabetes. 57:2595–2602. 2008.
View Article : Google Scholar
|
|
27
|
Kirwan JP, Hauguel-De Mouzon S, et al:
TNF-α is a predictor of insulin resistance in human pregnancy.
Diabetes. 51:2207–2213. 2002.
|
|
28
|
Qureshi M: Avian macrophage and immune
response: an overview. Poult Sci. 82:691–698. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Deng S, Wu Q, Yu K, et al: Changes in the
relative inflammatory responses in sheep cells overexpressing of
toll-like receptor 4 when stimulated with LPS. PLoS One.
7:e471182012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hotamisligil G: The role of TNFα and TNF
receptors in obesity and insulin resistance. J Intern Med.
245:621–625. 1999.
|
|
31
|
Takeda K and Akira S: TLR signaling
pathways. Semin Immunol. 16:3–9. 2004. View Article : Google Scholar
|
|
32
|
Paik YH, Schwabe RF, Bataller R, Russo MP,
Jobin C and Brenner DA: Toll-like receptor 4 mediates inflammatory
signaling by bacterial lipopolysaccharide in human hepatic stellate
cells. Hepatology. 37:1043–1055. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Catalano P, Highman T, Huston L and
Friedman J: Relationship between reproductive hormones/TNF alpha
and longitudinal changes in insulin sensitivity during gestation.
Diabetes. 45:175A1996.
|
